Reporting owner · Q3 2026 · CIK 1347535

Divita Charles III: insider trades.

Divita Charles III reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($224K), across 1 company.

Transactions
6
Purchases (P)
0
Sales (S)
2
Companies
1
Name as filed
DIVITA CHARLES III

Companies

CompanyRelationshipTransactions
Teladoc Health, Inc. (TDOC)Director, Officer · CHIEF EXECUTIVE OFFICER6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-11Teladoc Health, Inc.S17,805$6.1465,535Form 4
2026-09-10Teladoc Health, Inc.M3,642—444,180Form 4
2026-09-10Teladoc Health, Inc.M39,160—483,340Form 4
2026-09-02Teladoc Health, Inc.S18,327$6.3440,538Form 4
2026-09-01Teladoc Health, Inc.M1,966—458,865Form 4
2026-09-01Teladoc Health, Inc.M42,277—456,899Form 4

Questions

What stock did Divita Charles III buy or sell?

Divita Charles III reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($224K), across 1 company.

Is Divita Charles III the same person as other filers with this name?

This page covers SEC CIK 1347535 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/divita-charles-iii-1347535.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.